Treating sleep disorders using desloratadine
US6265414A · kind A · utility
14Cited by
24References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2000 |
| Grant date | Jul 24, 2001 |
| Priority date | — |
| Expiry date | May 3, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating and/or preventing sleep disorders in a human afflicted with upper airway passage allergic inflammation and/or congestion associated with allergic rhinitis, including seasonal allergic rhinitis or perennial allergic rhinitis, by administering a therapeutically effective amount of desloratadine, alone or in combination with other active such as a decongestant, e.g., pseudoephedrine are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.